Menu Search

Sweden

OMX Stockholm 30Last 5 days
Last price3,021.82

Loading...

SEK overview

PairLatest rateToday's change1 year change
SEKGBP0.0803
GBP		-0.00004 / -0.05%0.004 / 5.27%
Today
0.0756Mar 20 20250.0827Feb 11 2026
SEKEUR0.093
EUR		-0.00005 / -0.05%0.0023 / 2.48%
Today
0.0879Jul 16 20250.0952Feb 03 2026
SEKUSD0.1069
USD		-0.0001 / -0.09%0.0078 / 7.87%
Today
0.0979Mar 20 20250.1144Jan 27 2026
SEKJPY17.02
JPY		-0.0047 / -0.03%2.23 / 15.07%
Today
14.34Apr 07 202517.66Jan 23 2026
SEKAUD0.1513
AUD		-0.00005 / -0.03%-0.0039 / -2.54%
Today
0.1505Mar 16 20260.1687Apr 09 2025
SEKCAD0.1463
CAD		-0.0002 / -0.14%0.0047 / 3.28%
Today
0.1399Apr 11 20250.1552Jan 27 2026
SEKCNY0.7363
CNY		-0.0018 / -0.25%0.0192 / 2.68%
Today
0.709Mar 20 20250.7955Jan 27 2026
SEKCHF0.0842
CHF		-0.0001 / -0.12%-0.0031 / -3.55%
Today
0.082Jul 16 20250.0897Apr 02 2025

Equity fund country flows

This chart shows the cumulative weekly equity in country flows into or out of Sweden in USD. EPFR Global provides global coverage of foreign investor flows, tracking over 15,000 funds domiciled around the world.
As of May 19 2021.

Market movers

Constituents of the OMX Stockholm 30 with the highest percent gain over one day.
ListingLastChangeVolume
EQT ABEQT:STO281.60
SEK		+2.70
+0.97%		104.31k
Volvo ABVOLV B:STO322.50
SEK		+2.20
+0.69%		121.09k
Evolution AB (publ)EVO:STO590.00
SEK		+3.00
+0.51%		6.96k
Telia Company ABTELIA:STO48.04
SEK		+0.24
+0.50%		102.52k
H & M Hennes & Mauritz ABHM B:STO180.50
SEK		+0.600
+0.33%		18.37k
Tele2 ABTEL2 B:STO193.20
SEK		+0.600
+0.31%		21.58k
AstraZeneca PLCAZN:STO1,798.00
SEK		+5.50
+0.31%		3.42k
Swedbank ABSWED A:STO335.30
SEK		+1.00
+0.30%		61.99k
Svenska Handelsbanken ABSHB A:STO139.05
SEK		+0.20
+0.14%		189.73k
Data delayed at least 15 minutes, as of Mar 17 2026 08:08 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.